tweetindex
RU

The Lancet ✓

@TheLancet · London, New York, Beijing · joined 27 Mar 2009

Welcome to The Lancet, one of the world’s leading medical journals, published weekly since 1823.

763 911Followers
456Following
28 064Posts total
587.4KViews on collected posts

Последние посты

The current tests for endometrial cancer are invasive and often painful. In The Lancet Obstetrics, Gynaecology, & Women’s Health, a study suggests that a simple non-invasive test could transform cancer screening for women with postmenopausal bleeding: https://t.co/ApQ44ZPZmS htt
Vaginal and urine samples showing endometrial cancer (true positive case; upper row) and no malignant cells (true negative case; lower row). Top row: SurePath (CytoRich Red, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) cytology slides (Papanicolaou stain): endometrial adenocarcinoma. Urine sample, \u00D7 600 magnification (left) and vaginal sample, \u00D7 600 magnification (right) from the study participant SMH0170 showing adenocarcinoma, clinical outcome grade 1 stage IB endometrioid adenocarcinoma, true positive. Bottom row: SurePath cytology slides (Papanicolaou stain): no malignant cells seen. Urine sample, \u00D7 400 magnification (left) and vaginal sample, \u00D7 600 magnification (right) from the study participant SMH0212 with no malignant cells seen, true negative. Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.
2K views · 5 likes · 2 reposts · 2 replies Open on X →
Peripheral arterial disease (PAD) affects more than 300 million people worldwide—yet it remains under-recognised, underdiagnosed, and undertreated. A new Series aims to address this major health burden: https://t.co/krpoT5agr5 https://t.co/cPddZnq5rS
Figure showing typical regions of vessel involvement in people with PAD and illustration of the life course of affected people from asymptomatic PAD through intermittent claudication to CLTI, with reported progression rates and major amputation risk as well as death rates at the symptomatic disease stage. CLTI=chronic limb-threatening ischaemia. PAD=peripheral arterial disease. Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.
17.2K views · 221 likes · 63 reposts · 3 replies Open on X →
Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, find the EVOKE and EVOKE+ trials. Find out more ▶️ https://t.co/ZIM8IbuX5u #WorldAlzheimersDay https://t.co/1F7OJCPr0A
Research in context panel for Lancet paper \"Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials\". Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.
51.7K views · 152 likes · 50 reposts · 11 replies Open on X →
The field of Alzheimer’s disease has seen transformative advances that are beginning to reshape clinical practice. On #WorldAlzheimersDay, read a Seminar summarising the progress made and highlight the unmet needs and priorities for future research: https://t.co/4zgXMF2Dt8 https
0:31
17.5K views · 147 likes · 45 reposts · 9 replies Open on X →
Blood test can identify signs of Alzheimer’s Disease decades before symptoms, suggests study in The Lancet. Find out more: https://t.co/3w6rX8kdOA #WorldAlzheimersDay https://t.co/G8u4cZ0RaQ
Research in context panel for the paper published in The Lancet entitled \"Alzheimer\u2019s disease neuropathology plasma biomarkers and cognition in midlife: a community-based cohort study\". Copyright: 2026 Elsevier Ltd. All rights reserved.
25.6K views · 311 likes · 115 reposts · 5 replies Open on X →
"...used appropriately, data can free us from the errors and prejudices that currently shape our thinking and decision making." Richard Horton's latest Offline: The emptiness of the quantified self: https://t.co/pYawsPCJNv 23.4K views · 28 likes · 5 reposts · 2 replies Open on X →
ICYMI - A new Series in @TheLancetNeuro explores how Alzheimer's disease clinical practice might evolve over the next 5–10 years, focusing on: ➡️ fluid biomarkers ➡️ neuroimaging ➡️ clinical pathways for cognitively unimpaired individuals Read now: https://t.co/IW2XMLSSsB https:
Promotional card for The Lancet Neurology Series on Future Directions of Alzheimer's Disease and Related Disorders. Image on card: A gloved hand holds up a sample tube in front of a computer screen displaying brain scans. There is a rack of sample tubes in the foreground. Copyright: Tek Images/Science Photo Library.
10.2K views · 27 likes · 4 reposts · 3 replies Open on X →
What if cancer prevention were as personalised as cancer treatment? The new @GustaveRoussy–Lancet Lecture sets out the case for precision prevention and early detection—matching interventions to individual risk, while building the workforce and health systems needed to deliver h
Quote from The Gustave Roussy-Lancet lecture on Precision prevention and early detection: framework for a new clinical cancer control pathway. Quote reads: \"The defining challenge of the next decade of cancer control is not to build another test, but to build the discipline that uses them.\"
10.6K views · 43 likes · 17 reposts · 1 replies Open on X →
Despite serious symptoms, asthma is often underdiagnosed and mismanaged, which—in the worst-case scenarios—can be fatal. A new Editorial explores the unmet needs of people living with severe asthma: https://t.co/4GYCzNwa3l 15.7K views · 27 likes · 9 reposts · 0 replies Open on X →
What makes a meta-analysis believable? In our latest issue, a new Viewpoint outlines how to identify meta-analyses that merit clinical confidence. Explore the full issue: https://t.co/ms0qkr6Fr3 https://t.co/pHm1BEvo7j
Cover of The Lancet September 19, 2026 issue. Quote reads: Meta-analyses are not definitive truths, but rather structured efforts to interpret incomplete, evolving, and sometimes inconsistent evidence.
38.3K views · 412 likes · 166 reposts · 7 replies Open on X →
ICYMI - A genetically modified pig kidney kept a man off dialysis for nine months before a successful human kidney transplant, according to a world-first report in The Lancet. Read now: https://t.co/lJuHejCJIS https://t.co/Sd3Koji8Ya
Figures showing (A) Total daily urine output (mL) during the first week after xenotransplantation. (B) Serum creatinine and eGFR throughout the xenograft period. Note that scales on y axes differ between plots. Vertical dashed lines indicate for-cause kidney biopsies\u2014key histopathological findings are annotated: day 14, Banff IIA TCMR; day 176, MVI with endothelial injury; day 264, TMA with transplant glomerulopathy. (C) Serum sodium. (D) Serum potassium. All panels share a common x-axis representing days relative to xenotransplantation (day 0). eGFR=estimated glomerular filtration rate. MVI=microvascular inflammation. TCMR=T-cell-mediated rejection. TMA=thrombotic microangiopathy. Copyright: 2026 Elsevier Ltd. All rights are reserved.
24.4K views · 59 likes · 14 reposts · 0 replies Open on X →
A new AI tool could help doctors avoid unnecessary contrast-dye injections for some brain tumour patients, according to a study in The Lancet Medical Imaging & Theranostics. Explore the research: https://t.co/aU27WJ3qpx https://t.co/gZB8FCjzyX
Figure showing Brain tumour enhancement detection performance. Patient-level detection of enhancing tumour from non-contrast sequences in the overall cohort (A), stratified by dataset (B), pathologies (C), country of sample origin (D), age (available for 50\u22C59%) (E), and sex (available for 51\u22C57%) (F). Error bars in panels (A) and (F) represent bootstrapped 95% confidence intervals. AUROC=area under the receiver operating characteristic curve. Balanced Acc=balanced accuracy. BraTS=Brain Tumor Segmentation Challenge. BraTS-GLI=Post-treatment Glioma. BraTS-MEN=Meningioma. BraTS-METS=Metastases. BraTS-PEDs=Paediatric. BraTS-SSA=Sub-Saharan Africa. EGD=Erasmus Glioma Database. F1=F1 score. NHNN=National Hospital for Neurology and Neurosurgery. UCSF-PDGM=University of California San Francisco Preoperative Diffuse Glioma Dataset. UPENN-GBM=University of Pennsylvania Glioblastoma Dataset. Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.
12.3K views · 27 likes · 11 reposts · 1 replies Open on X →
ICYMI - Cardiovascular disease is one of the leading causes of maternal mortality & a major driver of morbidity. Yet pregnancy-related cardiovascular complications are often under-recognised & variably managed. A new Series examines the continuum of cardiovascular risk https://t
Midsection close-up of an expectant mother holding a red heart against her bare pregnant belly, sitting with folded baby clothes on her lap and a wooden crib in the blurred background. Credit: Rhenizara S/Getty Images. Overlay text: \"Examining cardiovascular disease and pregnancy\".
7.7K views · 8 likes · 2 reposts · 1 replies Open on X →
A new study assessed the efficacy and safety of mitapivat in adults with transfusion-dependent thalassaemia. The study found that mitapivat significantly reduced the transfusion burden and was generally well tolerated, showing a favourable benefit–risk profile. Read more: https:
(A) TRR, defined as reduction of at least 50% in transfused red blood cell units with a reduction of at least two units of transfused red blood cells in any consecutive 12-week period until week 48 compared with baseline; patients withdrawn from the study before week 12 (day 85) were considered non-responders. (B) TRR2, defined as at least a 50% reduction in transfused red blood cell units in any consecutive 24-week period until week 48 compared with baseline; patients withdrawn from the study before week 24 (day 169) were considered non-responders. (C) TRR3, defined as at least a 33% reduction in transfused red blood cell units between week 13 and week 48 compared with baseline; patients withdrawn from the study before week 48 were considered non-responders. (D) TRR4, defined as at least a 50% reduction in transfused red blood cell units between week 13 and week 48 compared with baseline; patients withdrawn from the study before week 48 were considered non-responders.
12.2K views · 21 likes · 6 reposts · 4 replies Open on X →
ICYMI - Guidelines recommend catheter ablation for symptom relief in patients with atrial fibrillation. In this study, catheter ablation did not demonstrate superiority over a sham procedure for improving atrial fibrillation-related quality of life at 6 months: https://t.co/5L5mz
Promotional card for a Lancet paper presented at ESC 2026: Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, shamcontrolled, multicentre trial
19.2K views · 44 likes · 15 reposts · 1 replies Open on X →
New US Medicare pricing policies could reshape global pharmaceutical markets, potentially driving up prices and delaying medicine launches worldwide, study suggests. Find out more: https://t.co/4KBcRG8Spc https://t.co/E9TMvZxz0l
Research in context panel for a paper published in The Lancet entitled \"Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study\". Copyright: 2026 Elsevier Ltd. All rights reserved.
11.2K views · 20 likes · 9 reposts · 0 replies Open on X →
⏰ Get writing—less than a month left to enter the 2025 Wakley Prize competition! Find out more about this year's theme: https://t.co/5XSbijRqB7 https://t.co/OorhYA5OEx
Promotional card for The Lancet's Wakley Prize Essay Competition. Text on card reads: The Wakley Prize Essay Competition: A call for submissions. Background image is of Thomas Wakley, who founded The Lancet in 1823.
17.9K views · 18 likes · 8 reposts · 0 replies Open on X →
In July, the winners of the Lancet–@ElsFoundation Evidence to Impact Awards were announced. Three research teams were recognized for outstanding work translating health evidence into real-world impact in underserved communities. Find out more about their work in The Lancet ⤵️ 16K views · 16 likes · 2 reposts · 1 replies Open on X →
Richard Horton's latest Offline: The tragic fallacy of global health reform https://t.co/KfJObSG0OG 19.6K views · 19 likes · 2 reposts · 0 replies Open on X →
New Editorial—Gene-editing therapies: delivering safely for patients https://t.co/Vj8x81Q6OO https://t.co/OZnsJwgFfw
Quote from The Lancet's September 12, 2026 Editorial. Quote reads: \"The promise of therapeutic gene editing can only be realised with a renewed commitment to risk management, regulatory oversight, transparency, and a spirit of respectful cooperation between researchers, clinicians, and patients and their families.\"
13.8K views · 18 likes · 1 reposts · 0 replies Open on X →
On the cover this week, authors of a new letter argue that global science can serve as a foundation for international cooperation, even when politics fails. Read this & more: https://t.co/YN2hunT3fc https://t.co/13Ap76zjzR
Cover of The Lancet's September 12, 2026 issue. Quote on cover: \"Science cannot stop armies or resolve diplomatic failures. When formal political institutions weaken, science can preserve communication channels, common standards of evidence, and trust across borders.\"
11.1K views · 67 likes · 14 reposts · 2 replies Open on X →
In @TheLancetNeuro, a new Series explores how Alzheimer's disease clinical practice might evolve over the next 5–10 years, focusing on: ➡️ fluid biomarkers ➡️ neuroimaging ➡️ clinical pathways for cognitively unimpaired individuals Read now: https://t.co/hyvzyBmT9j https://t.co/
Promotional card for The Lancet Neurology Series on Future Directions of Alzheimer's Disease and Related Disorders. Image on card: A gloved hand holds up a sample tube in front of a computer screen displaying brain scans. There is a rack of sample tubes in the foreground. Copyright: Tek Images/Science Photo Library.
10K views · 54 likes · 15 reposts · 4 replies Open on X →
"So, should you be optimistic about the future of @WHO? You have to be. There is no other choice." In a new Offline, Richard Horton discusses the current challenges facing the WHO and its upcoming leadership transition. Read now: https://t.co/3bWtExknXq 13.9K views · 17 likes · 5 reposts · 1 replies Open on X →
What we eat, where we live and how we work have long been understood as determinants of health. But what we scroll, what algorithms feed us and how platforms are designed are determinants of health too. Join us and DTH-Lab for the launch of a new Lancet Series. October 5, 13:00 11K views · 71 likes · 22 reposts · 1 replies Open on X →
"...cardiovascular health should be central to maternal care." Our latest Editorial discusses cardiovascular health challenges during pregnancy and the need for better preventive care. Read now: https://t.co/LAdWWh1jpi https://t.co/nGQxBKRnJc 10.3K views · 15 likes · 1 reposts · 0 replies Open on X →
🫀 What excited us at #ESCCongress? Hear Lancet editors discuss the most interesting sessions, areas to watch, and the status of AI in cardiology right now. https://t.co/jokhMmmng1 30.2K views · 9 likes · 3 reposts · 0 replies Open on X →
Cardiovascular disease is one of the leading causes of maternal mortality & a major driver of morbidity. In our latest issue, a new Lancet Series examines the continuum of cardiovascular risk surrounding pregnancy. Read this & more: https://t.co/zWykggrz3m https://t.co/XvtPZIfv 12K views · 75 likes · 28 reposts · 5 replies Open on X →
A new Clinical Rounds article emphasizes the importance of resisting cognitive bias in cancer patients through reflective reassessment and biopsy confirmation. Read now: https://t.co/TIWgSRg41A https://t.co/9EPZ7fw92B 9K views · 22 likes · 9 reposts · 2 replies Open on X →
The Lancet Surgery & Anaesthesiology has published its first piece of content online 📝 Ntuli Kapologwe & colleagues highlight the importance of global surgery to global health and the need for synergy between the @WHO ECO Strategy & NSOAPS. Read now: https://t.co/OQZBTuukms http 12.4K views · 21 likes · 4 reposts · 0 replies Open on X →
@TheLancet Because they have been vaccinated with the Covid Bio weapon 💉??? Did I win ?? 28 views · 0 likes · 0 reposts · 0 replies Open on X →

На фоне аккаунтов своего размера

37 постов за последние 90 дней рядом с диапазоном 100K–1M подписчиков. обычный охват для своего размера, отклик слабее, чем у большинства.

Медианные просмотры12 353этот аккаунт5 983медиана для 100K–1M
Охват, %1.62%этот аккаунт1.49%медиана для 100K–1M
Вовлечённость, %0.31%этот аккаунт0.93%медиана для 100K–1M
ПоказательЭтот аккаунтМедиана для 100K–1MОтношение
Медианные просмотры на пост12 3535 9832.06×
Охват (просмотры ÷ подписчики)1.62%1.49%1.09×
Вовлечённость0.31%0.93%0.34×

Другие в этом диапазоне →   Сравнить с другим аккаунтом →   Как считаются эти ориентиры →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

12.2K14 Sep
7.7K15 Sep
12.3K16 Sep
24.4K17 Sep
38.3K18 Sep
15.7K
10.6K
10.2K19 Sep
23.4K
25.6K20 Sep
17.5K21 Sep
51.7K
17.2K22 Sep
2K23 Sep

Last 14 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.28%14 Sep
0.14%15 Sep
0.34%16 Sep
0.32%17 Sep
1.54%18 Sep
0.23%
0.58%
0.35%19 Sep
0.17%
1.70%20 Sep
1.17%21 Sep
0.42%
1.68%22 Sep
0.46%23 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes58.5%1 974 in total
Reposts19.2%647 in total
Replies2.0%66 in total
Quotes1.2%40 in total
Bookmarks19.2%649 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

21 Sep

Daily snapshots since 21 Sep 2026; the dashed line is the starting count.

Похожие аккаунты